Company Filing History:
Years Active: 1995-1997
Title: Barbara J England: Innovator in Glycated Hemoglobin Testing
Introduction
Barbara J England is a notable inventor based in Milwaukee, WI (US). She has made significant contributions to the field of medical diagnostics, particularly in the rapid determination of glycated hemoglobin. With a total of 3 patents to her name, her work has the potential to improve diabetes management and patient care.
Latest Patents
One of her latest patents is titled "Methods and reagents for the rapid determination of glycated hemoglobin." This invention introduces a rapid, continuous test for glycated hemoglobin using a non-equilibrium affinity binding method. The method utilizes agarose beads derivatized with 3-aminophenylboronic acid, which specifically bind glycated hemoglobin. This solid phase is incorporated into a sample processor card that is modified to mix and separate the test solution from the solid phase prior to absorbance readings. Two absorbance readings are taken on the test solution: one immediately after mixing the reagent/diluent with the specimen, and another after a significant amount of binding has occurred. A linear correlation between total glycated hemoglobin and hemoglobin A.sub.1c allows for standardization and reporting of units equivalent to % hemoglobin A.sub.1c. Additionally, stable glycated hemoglobin solutions for use as standards in the assay, along with a method for preparing these standards, are also disclosed.
Career Highlights
Barbara J England is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has focused on developing innovative solutions for diabetes care, enhancing the accuracy and efficiency of glycated hemoglobin testing.
Collaborations
Throughout her career, Barbara has collaborated with esteemed colleagues, including Michael D Fiechtner and John M Ramp. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Barbara J England's contributions to the field of glycated hemoglobin testing exemplify her dedication to innovation in medical diagnostics. Her patents not only enhance the accuracy of diabetes management but also reflect her commitment to improving patient outcomes.